16 January 2025 in BMJ Public Health
Introduction: Childhood illness and hospitalisation result in both direct and indirect costs to families before, during and after admission. We aimed to estimate the catastrophic expenditure during hospitalisation for children with acute illness. Methods: This was a prespecified cross-sectional substudy nested within two prospective studies. Participants were recruited and interviewed from three rural and three urban hospitals in Kenya and Uganda. A costing questionnaire was administered to the caregivers of 731 children hospitalised for acute illness to evaluate direct and indirect costs incurred by caregivers and families. Costs incurred were compared for families with children both with and without complicated severe malnutrition (CSM). Catastrophic out-of-pocket expenditure exceeding 10% and 25% of monthly income was assessed. Results: The median (IQR) total cost during hospitalisation per child was US$47 (US$24–US$84), with higher costs for children with CSM, especially during hospitalisation (US$56 (US$26–US$99) vs US$36 (US$20–US$65); p<0.001). During hospitalisation, bed charges followed by food were the main cost drivers. Caregivers reported losing a median of 7 (4–11) days of productive time during a child’s hospitalisation with a mean loss of income of US$10 (SD US$25.6, median US$0 (US$0–US$10)). 92% and 74% of households experienced catastrophic expenditure at thresholds of 10% and 25% of monthly income, respectively. Caregivers reported borrowing, selling property and withdrawing other children from school to cope with costs. Conclusions: Despite intentions of free healthcare services for under 5, families of acutely ill children very commonly faced catastrophic expenditure, especially for children with CSM. Interventions aimed at supporting financial protection, reducing additional healthcare costs, and lowering health service charges may help prevent catastrophic expenditures.
14 March 2026 in Nephrology Dialysis Transplantation
Urinary albumin-to-creatinine ratio (uACR) and protein-to-creatinine ratio (uPCR) are established markers for risk stratification in pediatric chronic kidney disease (CKD), yet their relative strength of association with CKD progression remains unclear. We compared a head-to-head evaluation of uACR and uPCR associations with estimated glomerular filtration rate (eGFR) decline and kidney survival in a large pediatric CKD cohort. We analyzed 596 children aged 6–17 years with CKD stages 3–4 from the 4C cohort. Baseline uACR and uPCR were log-transformed and z-standardized. CKD progression was evaluated by annual eGFR slope and a composite kidney outcome (50% eGFR loss, eGFR <10 mL/min/1.73m², or kidney replacement therapy). Associations per 1-SD increase were estimated using adjusted linear mixed-effect and Cox models. Differences in effect sizes were assessed using bootstrap-based bias-corrected and accelerated 95% confidence intervals (CI). Mean (SD) age was 12.4 (3.3) years; 70% had congenital anomalies of the kidneys and urinary tract (CAKUT). Median (IQR) eGFR was 28 (14) mL/min/1.73m². Over a median follow-up of 2.5 (3.8) years, 334 events occurred. A 1-SD increase in log-uACR and log-uPCR was associated a 2.17-fold (95% CI: 1.84 to 2.55) and 1.70-fold (95% CI: 1.52 to 1.90) higher risk of the composite outcome, respectively; uACR showed a 28% stronger association (|$\frac{{H{{R}_{\textit{uACR}}}}}{{H{{R}_{\textit{uPCR}}}}}$| = 1.28; 95% CI: 1.12 to 1.53). No relative difference was found in overall eGFR slope change (slope ∆uACR-slope ∆uPCR= -0.05; 95% CI -0.50 to 0.24), but uACR showed stronger associations in children with advanced CKD and severe proteinuria. Both uACR and uPCR were independently associated with CKD progression in this pediatirc cohort. In direct comparison, uACR demonstrated stronger associations with adverse kidney outcomes, suggesting a comparatively greater prognostic signal and supporting current guideline emphasis on albuminuria for risk stratification and intervention outcome monitoring.